Efficacy of add‐on therapy with intravenous immunoglobulin in steroid hyporesponsive DRESS syndrome
Abstract Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare, potentially life‐threatening, delayed, drug‐induced hypersensitivity reaction. Immediate withdrawal of the culprit drug and administration of systemic corticosteroids is the most widely accepted treatment. How...
| Published in: | Clinical and Translational Science |
|---|---|
| Main Authors: | Da Woon Sim, Jieun Yu, Young‐Il Koh |
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-03-01
|
| Online Access: | https://doi.org/10.1111/cts.13201 |
Similar Items
Comparative study between the efficacy of Intravenous Immunoglobulin alone versus the efficacy of Intravenous Immunoglobulin combined with Steroids in treatment of Acute Myocarditis in Pediatric patients in Qena University Hospital
by: Alaa Abd El-sabour Bashier, et al.
Published: (2024-01-01)
by: Alaa Abd El-sabour Bashier, et al.
Published: (2024-01-01)
Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children
by: Jiaojiao Liu, et al.
Published: (2025-03-01)
by: Jiaojiao Liu, et al.
Published: (2025-03-01)
Kawasaki disease shock syndrome rescued by a combination of extracorporeal membrane oxygenation, steroids, and intravenous immunoglobulin
by: Chanyoung Chung, et al.
Published: (2022-06-01)
by: Chanyoung Chung, et al.
Published: (2022-06-01)
Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01)
Use of Intravenous Immunoglobulins in Intensive Therapy
by: E. A. Latysheva, et al.
Published: (2012-06-01)
by: E. A. Latysheva, et al.
Published: (2012-06-01)
Efficacy of Intravenous Immunoglobulins against Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids: A Case Report
by: Takumi Tsuchida, et al.
Published: (2023-03-01)
by: Takumi Tsuchida, et al.
Published: (2023-03-01)
Therapeutic efficacy of intravenous immunoglobulin in ulcerative colitis
by: LONG Qian, et al.
Published: (2025-04-01)
by: LONG Qian, et al.
Published: (2025-04-01)
The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
by: Soon‐Tae Lee, et al.
Published: (2022-05-01)
by: Soon‐Tae Lee, et al.
Published: (2022-05-01)
A Case Report of Steroid-Resistant Cryptogenic Organizing Pneumonia Managed with Intravenous Immunoglobulins
by: Christian Akem Dimala, et al.
Published: (2021-01-01)
by: Christian Akem Dimala, et al.
Published: (2021-01-01)
Renal transplant in a patient with idiopathic thrombocytopenic purpura refractory to steroid and intravenous immunoglobulin
by: Shubham Agarwal, et al.
Published: (2019-01-01)
by: Shubham Agarwal, et al.
Published: (2019-01-01)
Intravenous Immunoglobulin Therapy in COVID-19 Disease
by: Öner Özdemir, et al.
Published: (2021-06-01)
by: Öner Özdemir, et al.
Published: (2021-06-01)
A retrospective study on the efficacy of Roxadustat in peritoneal dialysis patients with erythropoietin hyporesponsiveness
by: Jie Liu, et al.
Published: (2024-05-01)
by: Jie Liu, et al.
Published: (2024-05-01)
Efficacy of intravenous immunoglobulin in children with drug-resistant epilepsy
by: Aya Ebdalla, et al.
Published: (2026-04-01)
by: Aya Ebdalla, et al.
Published: (2026-04-01)
Erythropoietin hyporesponsiveness among egyptian hemodialysis patients
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)
by: Salah Eldin Khedr PhD, et al.
Published: (2017-06-01)
Ionomycin Treatment Renders NK Cells Hyporesponsive.
by: Gema Romera-Cárdenas, et al.
Published: (2016-01-01)
by: Gema Romera-Cárdenas, et al.
Published: (2016-01-01)
An Exploratory Study of Daprodustat in Erythropoietin-Hyporesponsive Subjects
by: Borut Cizman, et al.
Published: (2018-07-01)
by: Borut Cizman, et al.
Published: (2018-07-01)
Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010-01-01)
by: J Gordon Millichap
Published: (2010-01-01)
Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin—a case report
by: J. A. Encarnación, et al.
Published: (2025-07-01)
by: J. A. Encarnación, et al.
Published: (2025-07-01)
CLINICAL LABORATORY INDICATORS OF PREGNANT WITH ANTIPHOSPHOLIPID SYNDROME IN COMPLEX THERAPY WITH USING INTRAVENOUS IMMUNOGLOBULIN
by: V. I. Linnikov
Published: (2016-06-01)
by: V. I. Linnikov
Published: (2016-06-01)
Pro-inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in Guillain-Barré syndrome
by: H Tekgül, et al.
Published: (1998-07-01)
by: H Tekgül, et al.
Published: (1998-07-01)
Intravenous immunoglobulin in dermatology
by: Dhar Sandipan
Published: (2009-01-01)
by: Dhar Sandipan
Published: (2009-01-01)
Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
by: Djamal Djeddi, et al.
Published: (2020-09-01)
by: Djamal Djeddi, et al.
Published: (2020-09-01)
Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01)
by: Hyo Min Park, et al.
Published: (2013-02-01)
Comparison of the Efficacy of Intravenous Immunoglobulin with Methylprednisolone as First-line Therapy in Multisystem Inflammatory Syndrome in Children: A Prospective Cohort Study
by: Navya S Manugu, et al.
Published: (2025-06-01)
by: Navya S Manugu, et al.
Published: (2025-06-01)
Idiotype-specific intravenous immunoglobulin for therapy of immunoglobulin kappa free light chain deficiency
by: Adina Elena Stanciu, et al.
Published: (2019-05-01)
by: Adina Elena Stanciu, et al.
Published: (2019-05-01)
Efficacy of intravenous immunoglobulin in the treatment of a COVID-19 patient
by: Stojanović Maja, et al.
Published: (2022-01-01)
by: Stojanović Maja, et al.
Published: (2022-01-01)
LOSS OF HSC STEMNESS IDENTITY IS ASSOCIATED WITH EXHAUSTION AND HYPORESPONSIVENESS IN GATA2 DEFICIENCY SYNDROME
by: Laëtitia Largeaud, et al.
Published: (2023-12-01)
by: Laëtitia Largeaud, et al.
Published: (2023-12-01)
Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012-08-01)
by: J Gordon Millichap
Published: (2012-08-01)
Hypotonic hyporesponsive episode and the 13-valent pneumococcal vaccine
by: Lampros Fotis, et al.
Published: (2014-08-01)
by: Lampros Fotis, et al.
Published: (2014-08-01)
Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?
by: Henry H. L. Wu, et al.
Published: (2022-08-01)
by: Henry H. L. Wu, et al.
Published: (2022-08-01)
Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
by: Yun Liu, et al.
Published: (2023-03-01)
by: Yun Liu, et al.
Published: (2023-03-01)
Use of plasmapheresis and intravenous immunoglobulins in pregnant women with antiphospholipid syndrome
by: E. S. Orlova, et al.
Published: (2025-01-01)
by: E. S. Orlova, et al.
Published: (2025-01-01)
Effectiveness of Intravenous Immunoglobulin for Management of Pain in Patients with Postpolio Syndrome
by: Min Cheol Chang, et al.
Published: (2021-01-01)
by: Min Cheol Chang, et al.
Published: (2021-01-01)
Successful treatment of Sneddon Syndrome with high dose intravenous immunoglobulin
by: Markus Reitmajer, et al.
Published: (2024-12-01)
by: Markus Reitmajer, et al.
Published: (2024-12-01)
Intravenous immunoglobulin therapy in erythromelalgia management: a case report
by: Renato Ádler Pomilio de Sousa, et al.
Published: (2025-03-01)
by: Renato Ádler Pomilio de Sousa, et al.
Published: (2025-03-01)
Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
by: Saladi SM, et al.
Published: (2008-09-01)
by: Saladi SM, et al.
Published: (2008-09-01)
ADVERSE EFFECTS OF INTRAVENOUS IMMUNOGLOBULIN THERAPY IN PATIENTS WITH ANTIBODY DEFICIENCY
by: A. Aghamohammadi, et al.
Published: (2003-09-01)
by: A. Aghamohammadi, et al.
Published: (2003-09-01)
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01)
by: S. A. Sel'kov, et al.
Published: (2014-07-01)
Efficacy of dexamethasone combined with intravenous immunoglobulin for the treatment of pediatric autoimmune encephalitis
by: Xiaolin Zhou, et al.
Published: (2025-03-01)
by: Xiaolin Zhou, et al.
Published: (2025-03-01)
Outcomes of Stevens–Johnson syndrome and toxic epidermal necrolysis in HIV-infected patients when using systemic steroids and/or intravenous immunoglobulins in Pietermaritzburg, South Africa
by: Antoinette V. Chateau, et al.
Published: (2019-07-01)
by: Antoinette V. Chateau, et al.
Published: (2019-07-01)
Similar Items
-
Comparative study between the efficacy of Intravenous Immunoglobulin alone versus the efficacy of Intravenous Immunoglobulin combined with Steroids in treatment of Acute Myocarditis in Pediatric patients in Qena University Hospital
by: Alaa Abd El-sabour Bashier, et al.
Published: (2024-01-01) -
Efficacy and Safety of Telitacicept as an Add-On Therapy for Refractory Immunoglobulin A Nephropathy or Immunoglobulin A Vasculitis Nephropathy in Children
by: Jiaojiao Liu, et al.
Published: (2025-03-01) -
Kawasaki disease shock syndrome rescued by a combination of extracorporeal membrane oxygenation, steroids, and intravenous immunoglobulin
by: Chanyoung Chung, et al.
Published: (2022-06-01) -
Intravenous Immunoglobulin Therapy in Myocarditis
by: Amir Hossein Mansourabadi, et al.
Published: (2020-08-01) -
Use of Intravenous Immunoglobulins in Intensive Therapy
by: E. A. Latysheva, et al.
Published: (2012-06-01)
